Arthneeti
Apollo Hospitals Enterprise LtdQ3 FY25

Apollo Hospitals Enterprise Ltd Q3 FY25 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹8,448P/E: 57.8Market Cap: ₹1.2L CrSector: Healthcare Services

Management growth scorecard

Revenue

N/A

Margin

N/A

Fundraise

N/A

Order

N/A

Capex

N/A

0 of 0 growth signals are positive — mixed outlook.

Full analysis

Revenue guidance

No information is provided regarding the same in the latest conference call.

See what Apollo Hospitals Enterprise Ltd management said on margin guidance — free account, 30 seconds.

Fundraise plans

No information is provided regarding the same in the latest conference call.

See what Apollo Hospitals Enterprise Ltd management said on order book — free account, 30 seconds.

Capex plans

No information is provided regarding the same in the latest conference call.

Track Apollo Hospitals Enterprise Ltd — get its next earnings analysis in your feed

How does Apollo Hospitals Enterprise Ltd rank vs peers in Healthcare Services?

Pro feature
ThisApollo Hospitals Enterprise Ltd
See where Apollo Hospitals Enterprise Ltd sits in Healthcare ServicesSee which companies these are, and every other name in the sector.Open rankings

How does Apollo Hospitals Enterprise Ltd rank in Healthcare Services?

Compare Apollo Hospitals Enterprise Ltd against every Healthcare Services company (Q3 FY25) on revenue, margins and earnings-call signals.

View Healthcare Services leaderboard →

Continue your research

What Apollo Hospitals Enterprise Ltd's management said in earlier quarters

Others in Healthcare Services this season

  • Narayana Hrudayalaya Ltd (Q2 FY27)

    Consolidated operating revenue for Q2 FY27: ₹28,440 Mn, up 73.0% YoY (Page 15, 16). Key investor presentation takeaways from Narayana Hrudayalaya Ltd's Q2 FY27

  • Artemis Medicare Services Ltd (Q2 FY27)

    Q2 FY27 consolidated revenue from operations: INR 31,104 Lacs, up 13.2% YoY (Page 39, 40, 20). Key investor presentation takeaways from Artemis Medicare Service

  • Max Healthcare Institute Ltd (Q2 FY27)

    Q2 FY27 Gross Revenue: ₹3,219 Cr, up 20% YoY (Page 4, 17) . Key investor presentation takeaways from Max Healthcare Institute Ltd's Q2 FY27 investor presentatio

  • Indegene Ltd (Q2 FY27)

    Revenue from operations for Q2 FY27: INR 11,223 million, up 39.5% YoY (Page 23, 15, 4) . Key investor presentation takeaways from Indegene Ltd's Q2 FY27 investo

Compare:vs Manipal Health Enterprises Ltdvs Max Healthcare Institute Ltdvs Aster DM Quality Care Ltd

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →